Aspen will launch cheaper obesity drugs in 2026

financialpost.com

Aspen Pharmacare plans to launch cheaper generic versions of popular obesity drugs like Ozempic in 2026. The South African drugmaker expects to produce these medications for less than half the current global price, targeting emerging markets and Canada initially. Aspen already has manufacturing and distribution agreements with companies holding patents for these blockbuster treatments.


With a significance score of 3.4, this news ranks in the top 7.9% of today's 28565 analyzed articles.

Get summaries of news with significance over 5.5 (usually ~10 stories per week). Read by 10,000+ subscribers:


Aspen will launch cheaper obesity drugs in 2026 | News Minimalist